ADOLFO JOSE
LOPEZ DE MUNAIN ARREGUI
IRAKASLE ELKARTUA
University of California, San Francisco
San Francisco, Estados UnidosUniversity of California, San Francisco-ko ikertzaileekin lankidetzan egindako argitalpenak (11)
2022
-
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Acta Neuropathologica, Vol. 144, Núm. 5, pp. 821-842
2021
-
A multicentre validation study of the diagnostic value of plasma neurofilament light
Nature Communications, Vol. 12, Núm. 1
2018
-
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
The Lancet Neurology, Vol. 17, Núm. 6, pp. 548-558
2017
-
A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction
Brain, Vol. 140, Núm. 4, pp. 1128-1146
-
The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics
PLoS ONE, Vol. 12, Núm. 6
2015
-
MAPT H1 haplotype is associated with late-onset Alzheimer's disease risk in APOE ε 4 noncarriers: Results from the dementia genetics Spanish consortium
Journal of Alzheimer's Disease, Vol. 49, Núm. 2, pp. 343-352
2014
-
Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients
Multiple Sclerosis Journal, Vol. 20, Núm. 14, pp. 1851-1859
2011
2010
-
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
Nature Genetics, Vol. 42, Núm. 3, pp. 234-239
2009
-
Differential micro RNA expression in PBMC from multiple sclerosis patients
PLoS ONE, Vol. 4, Núm. 7
2007
-
Increased transcriptional activity of milk-related genes following the active phase of experimental autoimmune encephalomyelitis and multiple sclerosis
Journal of Immunology, Vol. 179, Núm. 6, pp. 4074-4082